Wenfeng Li

5PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 21, 2026
An alternative EGFR activation by patient-derived R252C mutation promotes cancer progression.

Yajuan Zhang, Qizhen Fei, Yan Li

|Dec 25, 2023
Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer.

Yuanyuan Cheng, Zhe Ye, Yanru Xie

|Jun 24, 2022
Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas.

Xuedan Du, Jinting Wu, Ye Zhao

|Jul 30, 2020
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.

Shanshan Yu, Chuan Hu, Lixiao Liu

|Oct 02, 2019
Durable Response After Combination Of Concurrent Chemoradiotherapy And Anti-PD-1 Therapy In HER2-Negative Advanced Gastric Adenocarcinoma: A Case Report.

Shanshan Yu, Luya Cai, Fan Lin

Pageof 1

Frequent Collaborators

1 joint publications

Cheng Zhang

1 joint publications

Yajuan Zhang

1 joint publications

Yan Li

1 joint publications

Dong Gao